Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study have?
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study has 230 citations in the OpenAlex counts ScholarIQ stores.
When was Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study published?
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study has 2008 year in the ScholarIQ index.
What is the open-access status of Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study has green oa status in the ScholarIQ index.
What is the DOI of Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
The DOI for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is on the source record.
What is the PMID of Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
The PMID for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is on the source record.
What is the OpenAlex record for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study?
The OpenAlex for Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study is on the source record.